Friday, January 19, 2018
 
 
Chainbreaker Bike Ride Delivers nearly $1.4 million for Cancer Research at Masonic Cancer Center in its first year
MINNEAPOLIS and ST. PAUL, Minn., Jan. 19, 2018 /PRNewswire/ -- The Masonic Cancer Center, University of Minnesota, received a check for $1.389 million for cancer research from the inaugural Chainbreaker bike ride that took place in Augu.....
 
Precision Medicine Market to Demonstrate Progress at a ~12.48% of CAGR by 2022
19th January, 2018 - Altitude Movers Denver, an award-winning moving company in Denver Colorado specializes in home and office moving servic...
 
Telehealth Market – Doubling the market in just 2.4 years! The explosive power of ~29.8% CAGR By 2023
Austin, TX - Music Firsthand announces their Patreon campaign to secure funding for their weekly live streaming show featuring comedians interviewing m...
 
Southeast Radiation Oncology (SERO) Doctors Begin Working with SpaceOAR® Hydrogel for Prostate Cancer
CHARLOTTE, N.C., Jan. 19, 2018 /PRNewswire-PRWeb/ -- Southeast Radiation Oncology (SERO) has added a new innovative product for men choosing to undergo radiation therapy for prostate cancer. The new addition, SpaceOAR hydrogel, is mostly made of water and acts as a spacer between the prostate and the rectum and has been clini.....
 
Tumor Markers Immunoassay Market, 2025
DUBLIN, Jan. 19, 2018 /PRNewswire/ --
 
UB40 Featuring Ali, Astro & Mickey 'A Real Labour Of Love' The New Album Released March 2nd On UMe
LOS ANGELES, Jan. 19, 2018 /PRNewswire/ -- 'A Real Labour Of Love' is the new album from UB40 Featuring Ali, Astro & Mickey, to be released March 2nd on UMe. As founding members of
 



Let's Win and Partners Present Poster and Abstract at Gastrointestinal Cancer Symposium
NEW YORK, Jan. 19, 2018 /PRNewswire-USNewswire/ -- Let's Win! Pancreatic Cancer and partners are presenting a poster and publishing an abstract that highlights the first pancreatic cancer group Twitter chat dedicated to sharin.....
 
Adlai Nortye Enters into Global Licensing Agreement with Eisai for EP4 Antagonist
HANGZHOU, China, Jan. 19, 2018 /PRNewswire/ -- Adlai Nortye Biopharma Co., Ltd. (NEEQ: 870946) ("Adlai Nortye" or "the Company"), a biopharmaceutical company dedicated to discovery and commercialization of new and effective drugs, announced today that it had entered into a Global Licensing Agreement ("the Agreement") with Eis.....
 
Takara Bio USA, Inc. announces the use of the SMARTer™ ICELL8® Single-Cell System in clinical studies
MOUNTAIN VIEW, Calif., Jan. 19, 2018 /PRNewswire/ -- Takara Bio USA, Inc. (TBUSA, formerly Clontech Laboratories, Inc.), a wholly owned subsidiary of Takara Bio Inc., is proud to announce that City of Hope has recently procured a SMARTer ICELL8 Single-Cell System to perform high-level studies .....
 
Independent Imaging Review Confirmed Positive Data from Primary Analysis of REFLECT Trial Evaluating Lenvatinib Compared to Sorafenib in Unresectable Hepatocellular Carcinoma
WOODCLIFF LAKE, N.J., Jan. 19, 2018 /PRNewswire/ -- Eisai Inc. announced today results from the independent imaging review (IIR) of the REFLECT study (Study 304), a Phase 3 trial evaluating lenvatinib (marketed as Lenvima®), the company's multiple receptor tyrosine kinase inhibitor (including fibroblast growth fac.....
 
Wireless Patient Monitoring Market 2018 Global Analysis, Opportunities and Forecast To 2023
IT Asset Disposition Global Market   - Overview

The global IT asset disposition market is showing immense growth; m...
 


 
 
 
 
 
 
 
 
 
 
 
 
 





About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines